搜索临床试验以:选择化疗(长春瑞滨)
总计3757个结果
-
University Hospital, RouenFederation Francophone de Cancerologie Digestive; UNICANCER; Federation of Research in Surgery... 和其他合作者未知
-
Chinese Academy of SciencesXiangya Hospital of Central South University; Peking University People's Hospital; Peking Union... 和其他合作者招聘中
-
Samsung Medical CenterSamsung Genomic Institute招聘中
-
The Second Hospital of Shandong UniversityShandong Cancer Hospital and Institute; Wuhan YZY Medical Science and Technology Co., Ltd.未知
-
Cancer Research Group - Collaborative Group, Beirut...未知
-
Rutgers, The State University of New Jersey主动,不招人
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University 和其他合作者尚未招聘
-
Zhejiang Cancer Hospital未知
-
Chinese Academy of SciencesBeijing Friendship Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences 和其他合作者未知
-
Zhejiang Cancer Hospital未知
-
Children's Oncology GroupNational Cancer Institute (NCI)撤销淋巴瘤 | 未明确的儿童实体瘤,具体方案 | 白血病 | 脑和中枢神经系统肿瘤
-
Second Affiliated Hospital, School of Medicine,...Leiden University Medical Center尚未招聘
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.未知
-
GlaxoSmithKline终止
-
Fujian Cancer Hospital尚未招聘结直肠癌 II 期 | 结直肠癌 III 期
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)完全的
-
Pierian BiosciencesDiaTech Oncology and Vanderbilt University完全的
-
European Organisation for Research and Treatment...Canadian Cancer Trials Group; ECOG-ACRIN Cancer Research Group; Japan Clinical Oncology Group; Anticancer... 和其他合作者招聘中平滑肌肉瘤 | 脂肪肉瘤 | 腹膜后肉瘤美国, 日本, 法国, 西班牙, 加拿大, 意大利, 英国, 德国, 捷克语, 塞浦路斯, 荷兰, 澳大利亚, 波兰, 斯洛伐克, 丹麦
-
Shu-Zhong CuiXiangya Hospital of Central South University; Wuhan University; Peking University People's Hospital 和其他合作者未知
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Northwestern Memorial Hospital完全的
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La Roche未知
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre Laboratories主动,不招人
-
Central European Cooperative Oncology Group终止
-
Hoffmann-La Roche完全的